TB-500: Direct-Action Tissue Repair
TB-500 works at the tissue level, physically enabling repair cells to reach and heal damaged areas:
Cell Migration: By regulating actin polymerisation, TB-500 allows fibroblasts, endothelial cells, and other repair cells to migrate efficiently to sites of injury. This is one of the most fundamental requirements for wound healing.
Angiogenesis: TB-500 promotes the formation of new blood vessels, ensuring injured tissues receive adequate oxygen and nutrient supply during the repair process.
Inflammation Modulation: TB-500 reduces excessive inflammatory responses whilst maintaining the beneficial aspects of inflammation that initiate healing. This prevents chronic inflammation from impeding recovery.
Broad Tissue Coverage: Research demonstrates TB-500's efficacy across multiple tissue types — skin, muscle, tendon, cardiac tissue, and corneal tissue.
CJC-1295: Sustained Growth Hormone Amplification
CJC-1295 takes an upstream approach, amplifying the body's own growth hormone production:
GHRH Analogue: CJC-1295 binds to GHRH receptors on the anterior pituitary, stimulating somatotroph cells to produce and release growth hormone. Its modified structure gives it a significantly longer half-life than natural GHRH.
Sustained GH Elevation: Unlike compounds that produce a single GH spike, CJC-1295 creates a sustained elevation in baseline GH levels. This prolonged exposure maximises the downstream benefits of growth hormone.
IGF-1 Increase: The sustained GH release leads to increased hepatic IGF-1 production, which mediates many of GH's anabolic and repair effects throughout the body.
Systemic Benefits: CJC-1295's GH-mediated effects extend to body composition, sleep quality, skin health, metabolic function, and generalised tissue maintenance.
TB-500 + CJC-1295: A Complementary Stack
The combination of TB-500 and CJC-1295 offers researchers both immediate and sustained recovery benefits:
Immediate + Sustained: TB-500 provides direct, immediate tissue repair at injury sites. CJC-1295's sustained GH release creates a systemic pro-recovery environment that supports healing over weeks and months.
Local + Systemic: TB-500 acts locally — cell migration and angiogenesis target specific damage. CJC-1295 acts systemically — elevated GH and IGF-1 benefit every tissue in the body.
Acute + Chronic: TB-500 is ideal for acute recovery protocols (4-6 weeks). CJC-1295 is suited to longer-term protocols (8-12 weeks) for sustained GH optimisation.
ORYN Combined Cost: €119 + €109 = €228 for two 30-day pens. A cost-effective approach to comprehensive recovery research covering both direct repair and GH-mediated pathways.
